AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- BuzzFeed cuts 35% of workforce in restructuring move
Morgan Stanley on Amgen (AMGN): 'We believe the acquisition will be viewed as a modest positive'
August 4, 2022 10:03 AM EDTMorgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $253.00 price target on Amgen (NASDAQ: AMGN).
The analyst comments "We believe the acquisition will be viewed as a modest positive given investors are looking for mgt. to expand the pipeline and near-term revenues.... More
ChemoCentryx (CCXI) to Resume Trading at 8:30 a.m.
August 4, 2022 8:07 AM EDTChemoCentryx (NASDAQ: CCXI) to Resume Trading at 8:30 a.m.
... More